Ustekinumab linked with efficacy in treatment of Crohn’s disease: The UNITI-1 & 2, IM-UNITI trials
1. Ustekinumab achieved successful clinical induction in a greater proportion of patients with moderate to severe Crohn’s disease (CD) compared...
Matthew is an internal medicine resident physician at Brigham and Women’s Hospital. He previously attended Harvard Medical School, Harvard School of Public Health, and graduated from Harvard College in 2007 with a degree in History and Literature. From 2007-2010 he worked as a research coordinator on studies related to Alzheimer’s disease and frontotemporal dementia at the UCSF Memory and Aging Center. His interests include neurology, geriatrics, internal medicine, and healthcare policy, especially as it relates to chronic noncommunicable diseases.
1. Ustekinumab achieved successful clinical induction in a greater proportion of patients with moderate to severe Crohn’s disease (CD) compared...
1. There was no mortality benefit associated with receiving long-term oxygen supplementation in patients with stable chronic obstructive pulmonary disease...
1. Hospitals and provider organizations are increasingly compared and benchmarked based on short-term outcome measures, such as the risk-adjusted 30-day...
1. Patients with traumatic brain injury (TBI) and refractory intracranial hypertension following 2 stages of standard therapy who were then...
1. Individuals infected with HIV-1 who were randomized to receive antiretroviral therapy (ART) at trial enrollment had a 97% and...
1. Patients with moderate-to-severe plaque psoriasis treated with ixekizumab had significantly greater improvements in psoriasis compared to those treated with...
1. Critically ill patients in the ICU with severe acute kidney injury (AKI) who were randomized to early renal replacement...
1. In a large number of cases, the underlying etiology of sudden cardiac death (SCD) affecting children and young adults...
1. The treatment group receiving a combination of candesartan and hydrochlorothiazide demonstrated significant decreases in systolic and diastolic blood...
1. Previous studies have proven the efficacy of a killed whole-cell-only oral cholera vaccine administered as a two-dose regimen,...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.